Inflammatory myopathies

Subclinical myocardial involvement in a cohort of patients with antisynthetase syndrome

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

Subclinical myocardial involvement in ASSD is not rare (32%) although its clinical significance is uncertain. Myocardial oedema (T2) was the most frequent finding, followed by increased T1 and/or ECV values likely signalling interstitial fibrosis. Of note, patients in the acute phase showed elevated T2 values.

Study context

Population
Patients with antisynthetase syndrome (ASSD) without overt cardiac involvement (56% women; median age 56.3 years)3 in acute phase
Participants
25 patients
Outcome
Alterations in multiparametric CMR (subclinical myocardial involvement)
Methodological detailsmultiparametric cardiac magnetic resonance (CMR), native T1 and T2 mapping, extracellular volume (ECV) calculation
  • Multiparametric CMR
  • Native T1 and T2 mapping
  • ECV calculation

Main finding

As reported in the abstract

Pathological findings in CMR
Pathological CMR findings
8 (32%)
Of these: stable disease / acute phase
6 / 2
Elevated T1 mapping values
20% (5/25)
Elevated T2 mapping values
17% (4/25)
Elevated ECV
24% (6/25)

Observational data: associations, not effects.

Further findings

Acute-phase patients with increased T2 and ECV values
2

Original publication

Subclinical myocardial involvement in a cohort of patients with antisynthetase syndrome. Clin Exp Rheumatol. Published 14 March 2024. doi:10.55563/clinexprheumatol/tgcrtf

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.